JP2022500054A5 - - Google Patents

Info

Publication number
JP2022500054A5
JP2022500054A5 JP2021514594A JP2021514594A JP2022500054A5 JP 2022500054 A5 JP2022500054 A5 JP 2022500054A5 JP 2021514594 A JP2021514594 A JP 2021514594A JP 2021514594 A JP2021514594 A JP 2021514594A JP 2022500054 A5 JP2022500054 A5 JP 2022500054A5
Authority
JP
Japan
Prior art keywords
seq
nucleic acid
sequence
glycoprotein
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021514594A
Other languages
English (en)
Japanese (ja)
Other versions
JP7583448B2 (ja
JP2022500054A (ja
Filing date
Publication date
Priority claimed from DE102018215551.8A external-priority patent/DE102018215551A1/de
Application filed filed Critical
Publication of JP2022500054A publication Critical patent/JP2022500054A/ja
Publication of JP2022500054A5 publication Critical patent/JP2022500054A5/ja
Application granted granted Critical
Publication of JP7583448B2 publication Critical patent/JP7583448B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021514594A 2018-09-12 2019-09-12 抗腫瘍アレナウイルスおよびアレナウイルス変異体を生産するための方法 Active JP7583448B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102018215551.8 2018-09-12
DE102018215551.8A DE102018215551A1 (de) 2018-09-12 2018-09-12 Verfahren zur Herstellung eines antitumoralen Arenavirus sowie Arenavirusmutanten
PCT/EP2019/074307 WO2020053324A1 (en) 2018-09-12 2019-09-12 Method for producing an antitumoral arenavirus as well as arenavirus mutants

Publications (3)

Publication Number Publication Date
JP2022500054A JP2022500054A (ja) 2022-01-04
JP2022500054A5 true JP2022500054A5 (cg-RX-API-DMAC7.html) 2022-09-15
JP7583448B2 JP7583448B2 (ja) 2024-11-14

Family

ID=68138008

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021514594A Active JP7583448B2 (ja) 2018-09-12 2019-09-12 抗腫瘍アレナウイルスおよびアレナウイルス変異体を生産するための方法

Country Status (18)

Country Link
US (2) US12129281B2 (cg-RX-API-DMAC7.html)
EP (2) EP4019533A1 (cg-RX-API-DMAC7.html)
JP (1) JP7583448B2 (cg-RX-API-DMAC7.html)
KR (1) KR20210057782A (cg-RX-API-DMAC7.html)
CN (2) CN120158432A (cg-RX-API-DMAC7.html)
AU (1) AU2019340845B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021004451A2 (cg-RX-API-DMAC7.html)
CA (1) CA3111305A1 (cg-RX-API-DMAC7.html)
CL (1) CL2021000592A1 (cg-RX-API-DMAC7.html)
DE (1) DE102018215551A1 (cg-RX-API-DMAC7.html)
DK (1) DK3694868T3 (cg-RX-API-DMAC7.html)
ES (1) ES2908854T3 (cg-RX-API-DMAC7.html)
IL (1) IL281299B2 (cg-RX-API-DMAC7.html)
MX (1) MX2021002937A (cg-RX-API-DMAC7.html)
PH (1) PH12021550424A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202101970UA (cg-RX-API-DMAC7.html)
WO (1) WO2020053324A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202101833B (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022180203A1 (en) 2021-02-26 2022-09-01 Abalos Therapeutics Gmbh New virus particles for therapeutic purposes
IL326615A (en) * 2023-08-31 2026-04-01 Abalos Therapeutics Gmbh Virus particles with improved entry into tumor cells
CN117867030A (zh) * 2024-01-15 2024-04-12 苏州健雄职业技术学院 小鼠肺癌细胞系cmt167荧光素酶稳转细胞株的构建与应用
CN122357626A (zh) * 2025-10-30 2026-07-10 山东第一医科大学(山东省医学科学院) 一种抑制塔姆德病毒感染的方法及tcp1抑制剂的用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004034461B4 (de) 2004-07-16 2008-02-07 Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus Gentherapie solider Tumore durch retrovirale, mit Arenavirus-Glykoprotein pseudotypisierte Vektoren
CN103993012B (zh) 2007-12-27 2023-01-10 苏黎士大学 复制缺陷型沙粒病毒载体
KR20110074563A (ko) 2008-09-24 2011-06-30 메디뮨 엘엘씨 바이러스의 정제 방법
CN102439146A (zh) 2009-03-23 2012-05-02 巴斯德研究院 适合将免疫原性分子递送到细胞中的突变CyaA多肽及多肽衍生物
WO2012093340A2 (en) * 2011-01-07 2012-07-12 Bioscience Slovakia Viral diagnostics
JP6162818B2 (ja) * 2012-12-12 2017-07-12 チルドレンズ ホスピタル オブ イースタン オンタリオ リサーチ インスティチュート インコーポレイテッド 脳癌の治療のための組成物及び方法
DE102015207036A1 (de) * 2015-04-17 2016-10-20 Karl Sebastian Lang Arenaviren zur Anwendung bei der Behandlung und/oder Vorbeugung von Tumoren sowie Verfahren zur Herstellung von Arenaviren mit (verbesserten) tumorregressiven Eigenschaften
AU2016251687C1 (en) 2015-04-22 2023-07-27 CureVac SE RNA containing composition for treatment of tumor diseases
CN110167586B (zh) * 2016-11-04 2024-01-30 霍欧奇帕生物科技有限公司 作为癌症疫苗的复制-缺陷型沙粒病毒颗粒和三-节段沙粒病毒颗粒

Similar Documents

Publication Publication Date Title
JP2022163182A5 (cg-RX-API-DMAC7.html)
MX2023008825A (es) Efecto sinergico de smn1 y mir-23a en el tratamiento de la atrofia muscular espinal.
JP2007511216A5 (cg-RX-API-DMAC7.html)
US20250122244A1 (en) Method for producing an antitumoral arenavirus as well as arenavirus mutants
WO2013118544A1 (ja) タンパク質の分泌生産法
Wallat et al. High-resolution structure of the N-terminal endonuclease domain of the Lassa virus L polymerase in complex with magnesium ions
JP2019047790A (ja) L−アミノ酸を生産する微生物、及びそれを利用してl−アミノ酸を生産する方法
De Vlugt et al. Priming and realignment by the influenza a virus RdRp is dependent on the length of the host primers and the extent of base pairing to viral RNA
JP2020526202A5 (cg-RX-API-DMAC7.html)
CN108866099A (zh) 特异性抑制肺腺癌细胞miRNA-21-5p表达的重组慢病毒载体及其构建方法
US20080299617A1 (en) Methods and host cells for recombinant protein expression
RU2021104395A (ru) Способ продуцирования аренавируса, а также мутантов аренавируса с противоопухолевыми свойствами
US20230045095A1 (en) Compositions, Methods and Systems for the Delivery of Gene Editing Material to Cells
CN111467493A (zh) 人rev3l蛋白切割抑制剂及其应用
JP2024508823A5 (cg-RX-API-DMAC7.html)
JP2017046594A (ja) γ−Glu−Abuの製造法およびγ−Glu−Abuを含有する酵母エキスの製造法
NZ774584B2 (en) Method for producing an antitumoral arenavirus as well as arenavirus mutants
CN107502610A (zh) 一种靶向STAT3信号通路miRNA及其制备方法和应用
JP6874996B2 (ja) 人工rna制限酵素
CN109182279B (zh) 一种选择性杀灭肿瘤干细胞的新型溶瘤病毒及其构建方法
CN104946602A (zh) 具有肿瘤组织靶向性和抑癌基因修复性的重组溶瘤腺病毒Ad5-P16及其应用
HK40054624B (en) Method for producing an antitumoral arenavirus as well as arenavirus mutants
CN110538192A (zh) 一种HDAC4信号通路miRNA抑制剂及其过表达方法和应用
DOWHAM et al. STRUCTURE OF PHOSPHATIDYLSERINE DECARBOXYLASE
HK40054624A (en) Method for producing an antitumoral arenavirus as well as arenavirus mutants